Skip to main content
. 2014 Nov 20;9(11):e113612. doi: 10.1371/journal.pone.0113612

Figure 2. Striatal D2/3R availability for TRD, TRD AP and healthy control subjects.

Figure 2

Striatal D2/3 receptor (D2/3R) availability of TRD patients, TRD patients with antipsychotics (TRD AP) and healthy control subjects. The black dots represents the striatal D2/3R availability of each subject. The horizontal lines indicate the mean D2/3R availability of each group which is 0.84 for the TRD, 0.50 for the TRD AP and 0.81 for the healthy control subjects.